e-learning
resources
Munich 2006
Monday 04.09.2006
MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
W. M. Alberts (Tampa, United States of America)
Source:
Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Session:
MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Session type:
Meet the Professor
Number:
2875
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. M. Alberts (Tampa, United States of America). An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer. Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Missed lung cancer on chest radiography – does it affect the outcome?
Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques
Year: 2007
The chest physician as the lung cancer patient’s guide: defining the role of the modern day chest physician throughout the lung cancer continuum
Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy
Year: 2017
Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019
How should PET influence the management of lung cancer?
Source: Annual Congress 2013 –ME11 How should PET influence the management of lung cancer?
Year: 2013
Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy
Source: Eur Respir J 2012; 39: 1437-1442
Year: 2012
Delays in lung cancer management
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005
The evaluation of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 323s
Year: 2005
Tissue is the issue and beyond: proper sampling for diagnosis and staging of lung cancer by chest physicians as well as its alternatives
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019
COVID-19 and the management of thoracic cancer patients: challenges and recommendations
Source: ERS webinar 2020: COVID-19 and the management of thoracic cancer patients: challenges and recommendations
Year: 2020
The evidence on CT: lung cancer screening
Source: ERS Research Seminar 2018 – Lung Cancer Screening: from Trial to Practice
Year: 2018
Dealys in the diagnosis and treatment of lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 458s
Year: 2004
Lung cancer: clinical presentation and specialist referral time
Source: Eur Respir J 2004; 24: 898-904
Year: 2004
Our diagnostic time for lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 322s
Year: 2005
The role of bronchoscopy in the diagnosis of lung cancer: an audit to assess standards
Source: Eur Respir J 2001; 18: Suppl. 33, 62s
Year: 2001
Factors determining early adherence to a lung cancer screening protocol
Source: Eur Respir J 2007; 30: 532-537
Year: 2007
The role of bronchoscopy in the diagnosis of lung cancer and other diseases
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009
The need for early MDT assessment of lung cancer patients presenting with pain
Source: Eur Respir J 2003; 22: Suppl. 45, 432s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept